ReviewMaterials today. Bio2026
Surface bioengineering of lanthanide nanoparticles for theranostic applications: From hydrophilic modification to multimodal imaging and therapy.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lanthanide nanoparticles (LnNPs) are recognized as next-generation luminescent bioprobes due to their tunable emission spectra, long luminescence lifetimes, and high photostability. Although extensively studied, these nanomaterials have recently garnered renewed interest across biodetection, bioimaging, and therapeutics. To serve as suitable optical labels, LnNPs need to overcome inherent limitations such as hydrophobic surfaces, insufficient luminescence intensity, and limited environmental responsiveness. Accordingly, the integration of optical modulation, hydrophilic surface modification, and biofunctionality has become essential for advancing their biomedical applications. Recent surface engineering strategies have systematically addressed challenges related to hydrophilicity, colloidal stability, and biocompatibility, with substantial progress achieved. This review outlines mainstream approaches for hydrophilic surface modification and bio-functionalization of LnNPs, including ligand engineering, surface coating, and biomimetic modification. The design rationale and implementation of these methods are discussed, alongside representative applications in multimodal imaging and targeted therapy. Current challenges and future prospects in this rapidly evolving field are also summarized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.